CME Group Inc. $CME Shares Bought by Korea Investment CORP

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Korea Investment CORP increased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 222,073 shares of the financial services provider's stock after acquiring an additional 6,186 shares during the quarter. Korea Investment CORP owned about 0.06% of CME Group worth $58,914,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. SeaCrest Wealth Management LLC raised its stake in CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after purchasing an additional 40 shares during the period. OneAscent Financial Services LLC raised its stake in CME Group by 4.0% during the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock worth $293,000 after purchasing an additional 43 shares during the period. Ballentine Partners LLC raised its stake in CME Group by 0.8% during the first quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock worth $1,546,000 after purchasing an additional 45 shares during the period. Wealthcare Advisory Partners LLC raised its stake in CME Group by 3.6% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after purchasing an additional 47 shares during the period. Finally, Koshinski Asset Management Inc. raised its stake in CME Group by 1.4% during the first quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock worth $934,000 after purchasing an additional 48 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Down 1.4%

CME traded down $3.80 during trading hours on Friday, hitting $269.52. 1,591,589 shares of the company's stock were exchanged, compared to its average volume of 1,923,555. CME Group Inc. has a 12-month low of $206.44 and a 12-month high of $290.79. The firm has a 50 day moving average of $275.82 and a 200 day moving average of $268.31. The firm has a market cap of $97.13 billion, a P/E ratio of 26.09, a price-to-earnings-growth ratio of 4.95 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the firm earned $2.56 EPS. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. Analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio is presently 48.40%.

Insider Activity at CME Group

In other CME Group news, Director William R. Shepard bought 256 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Charles P. Carey sold 500 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director directly owned 4,900 shares in the company, valued at approximately $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of analyst reports. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Citigroup boosted their price target on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Piper Sandler boosted their price target on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Oppenheimer boosted their price target on shares of CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.